Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by slowing stomach emptying and signaling fullness to your brain—but the right dose varies significantly between individuals. Rather than a fixed number of injections, your treatment follows a dose-escalation schedule that typically spans 16 to 20 weeks, adjusting upward based on your tolerance and response. PlexusDx compounded semaglutide injections start at $149 per month, with your dose able to increase while your price remains the same.
Understanding Semaglutide Dose Escalation Schedules
Semaglutide dosing does not follow a one-size-fits-all approach. Clinical protocols typically begin at a low starting dose—usually 0.25 mg weekly—to allow your body to adapt and minimize nausea and gastrointestinal side effects. From there, your dose increases incrementally every week or every few weeks until reaching a maintenance dose that produces effective appetite suppression without intolerable adverse effects.
The standard escalation ladder moves from 0.25 mg to 0.5 mg to 1.0 mg to 1.7 mg to 2.4 mg over successive weeks. However, some patients achieve meaningful weight loss at lower maintenance doses, while others benefit from staying at higher doses. Your prescribing clinician assesses your individual tolerance and metabolic response at each step, adjusting the schedule if side effects warrant a slower titration.
Why Dose Matters for Weight Loss Outcomes
Research shows that semaglutide's weight-loss effect strengthens as dose increases, particularly across the 0.5 mg to 2.4 mg range. A 68-week randomized trial found that participants on 2.4 mg semaglutide weekly achieved approximately 15% body weight reduction, compared to roughly 10% at 1.7 mg. This dose-response relationship reflects semaglutide's mechanism: higher doses more potently activate GLP-1 receptors in the brain's hunger centers.
Reaching your optimal dose is critical because stopping too early may leave significant weight-loss potential unrealized. Conversely, some patients experience breakthrough nausea or appetite suppression that feels excessive at higher doses, meaning your clinician may keep you at a lower effective maintenance dose that balances efficacy and tolerability.
How PlexusDx Personalizes Your Dosing Journey
PlexusDx compounds semaglutide injections with flat monthly pricing starting at $149, ensuring your cost remains stable even as your dose increases during titration. This removes financial barriers to reaching your therapeutic dose and aligns pricing with clinical best practice: gradual dose escalation to tolerance and response.
For patients seeking deeper personalization, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month). This peptide-pathway genetic assessment maps 14 biological pathways and 150+ genetic insights, including variants in GLP1R (rs6923761) and GIPR (rs1800437) that influence how your body responds to semaglutide. These results help your clinician anticipate your optimal dose range and adjust expectations for weight loss.
PlexusDx delivers compounded semaglutide from licensed 503A compounding pharmacies to all 50 states without requiring insurance or membership. HSA and FSA funds may be applied, and no commitment is locked in beyond your chosen monthly plan.
Typical Timeline and Dose Milestones
Most semaglutide weight-loss protocols reach a maintenance dose within 16 to 20 weeks. For example, a patient starting 0.25 mg weekly may progress to 0.5 mg in week 2, 1.0 mg in week 3, 1.7 mg in week 4, and 2.4 mg in week 5—then remain at 2.4 mg as their maintenance dose. Others may slow this schedule if side effects occur, taking 8 to 10 weeks to reach 1.7 mg or 2.0 mg as their target.
Weight loss typically becomes noticeable after 4 to 8 weeks on an effective maintenance dose. Most patients report a 5% to 10% reduction in baseline weight by 12 weeks and cumulative losses of 15% to 22% by 52 weeks on semaglutide 2.4 mg. Individual outcomes vary based on diet, activity level, genetic factors, and consistency with weekly injections.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is a good starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected once weekly subcutaneously. This low beginning dose minimizes nausea and allows your gastrointestinal system to adjust. Your clinician will increase the dose every 1 to 2 weeks based on how you tolerate it and how your body responds to appetite suppression.
How many weeks does it take to reach the full therapeutic dose?
Most patients reach a maintenance dose within 16 to 20 weeks using standard titration protocols. However, timelines vary—some require 8 to 10 weeks if dose escalation is slowed due to side effects, while others may reach 2.4 mg in 4 to 5 weeks if they tolerate rapid escalation well. Your clinician personalizes the schedule to your individual needs.
Does my price go up if my semaglutide dose increases?
No. PlexusDx semaglutide injections are priced flat at $149 per month regardless of your dose level during titration or maintenance. Your dose may increase, but your monthly cost remains the same—a principle PlexusDx calls 'Your dose may need to go up. Your price won't.'
Can I lose weight on a lower semaglutide dose than 2.4 mg?
Yes. Many patients achieve meaningful weight loss at 1.0 mg, 1.7 mg, or lower doses depending on their metabolism, diet, and activity. Clinical evidence shows a dose-response relationship, but individual results vary widely. Your clinician may keep you at a lower maintenance dose if you achieve good weight loss with fewer side effects or if higher doses cause intolerable nausea.
How does the Precision Peptide Genetic Test help with semaglutide dosing?
The Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to GLP-1 therapy. These insights help your PlexusDx clinician predict your likely optimal dose range, anticipate side-effect risk, and tailor your escalation schedule for faster, more effective weight loss.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Many Mg Is 60 Units of Tirzepatide? A Detailed Guide to Understanding Dosage and Usage
What Insurance Covers Tirzepatide for Weight Loss?